BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15456904)

  • 1. Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line.
    Carpenter AJ; Porter AC
    Mol Biol Cell; 2004 Dec; 15(12):5700-11. PubMed ID: 15456904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
    Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
    Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
    Li H; Wang Y; Liu X
    J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
    Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
    Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
    Ryu H; Furuta M; Kirkpatrick D; Gygi SP; Azuma Y
    J Cell Biol; 2010 Nov; 191(4):783-94. PubMed ID: 21079245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin.
    Ryu H; Yoshida MM; Sridharan V; Kumagai A; Dunphy WG; Dasso M; Azuma Y
    Cell Cycle; 2015; 14(17):2777-84. PubMed ID: 26131587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
    Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
    Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl isomerase Pin1 functions in mitotic chromosome condensation.
    Xu YX; Manley JL
    Mol Cell; 2007 Apr; 26(2):287-300. PubMed ID: 17466629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres.
    d'Alcontres MS; Palacios JA; Mejias D; Blasco MA
    Cell Cycle; 2014; 13(9):1463-81. PubMed ID: 24626180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
    Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
    J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A.
    Escargueil AE; Larsen AK
    Biochem J; 2007 Apr; 403(2):235-42. PubMed ID: 17212588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
    Morgan SE; Beck WT
    Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic specific phosphorylation of serine-1212 in human DNA topoisomerase IIalpha.
    Ishida R; Takashima R; Koujin T; Shibata M; Nozaki N; Seto M; Mori H; Haraguchi T; Hiraoka Y
    Cell Struct Funct; 2001 Aug; 26(4):215-26. PubMed ID: 11699638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chromatin tether domain controls topoisomerase IIα dynamics and mitotic chromosome formation.
    Lane AB; Giménez-Abián JF; Clarke DJ
    J Cell Biol; 2013 Nov; 203(3):471-86. PubMed ID: 24217621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hydroquinone on expression of topoisomerase enzyme IIα in human bone marrow mononuclear cells].
    Shi YF; Yu K; Chen Y; Ren XZ; Bi LX; Qian HL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Sep; 28(9):660-3. PubMed ID: 21126478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
    Kratz AS; Richter KT; Schlosser YT; Schmitt M; Shumilov A; Delecluse HJ; Hoffmann I
    Cell Cycle; 2016 Dec; 15(24):3419-3431. PubMed ID: 27754753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
    Mo YY; Beck WT
    Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer.
    Zhou Q; Abraham AD; Li L; Babalmorad A; Bagby S; Arcaroli JJ; Hansen RJ; Valeriote FA; Gustafson DL; Schaack J; Messersmith WA; LaBarbera DV
    Oncogene; 2016 Sep; 35(38):4990-9. PubMed ID: 26947016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-step scaffolding model for mitotic chromosome assembly.
    Maeshima K; Laemmli UK
    Dev Cell; 2003 Apr; 4(4):467-80. PubMed ID: 12689587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.